Why is Pfizer stock falling after Q3 results?
Pfizer (PFE) stock fell even as the company beat forecasts with its Q3 results and increased its full-year outlook.Find out ...
Pfizer Beats Q3 Forecasts, Raises Guidance As Activist Investor Calls For Change
Pfizer’s third-quarter revenue and adjusted profit exceeded expectations, driven by strong sales of its Covid vaccine and ...
Pfizer’s Balanced Outlook: Hold Rating Amid Strong Q3 Results and Future Challenges
Morgan Stanley analyst Terence Flynn maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00.
Pfizer raises guidance as COVID franchise drives Q3 beat
Pfizer (PFE) stock gained after the company beat estimates with its Q3 2024 financials and raised its full-year guidance ...
BioSpace17h
Pfizer Exceeds Wall Street’s Q3 Expectations Amid Activist Investor Pressure
CEO Albert Bourla, who is under attack from activist investor Starboard Value, got a much-needed victory on Tuesday as Pfizer ...
Pfizer, McDonald’s Q3 Earnings to Set Early Market Tone; Alphabet, AMD Follow Post-Close
Pfizer’s rebound and McDonald’s E. coli impact headline pre-market earnings; post-close focus shifts to Alphabet and AMD. Get ...
Why Pfizer Stock Tumbled on Tuesday
Well before market open, Pfizer unveiled those quarterly results. These showed that the company's revenue was $17.7 billion, for a strong 32% year-over-year improvement when factoring sales of Covid ...